The Pathobiological Basis for Thrombotic Complications in COVID-19: a Review of the Literature

1.

Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–3. https://doi.org/10.1016/S0140-6736(20)30185-9.

CAS  Article  PubMed  PubMed Central  Google Scholar 

2.

Obi AT, Barnes GD, Napolitano LM, Henke PK, Wakefield TW. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection. J Vasc Surg Venous Lymphat Disord. 2021;9(1):23–35. https://doi.org/10.1016/j.jvsv.2020.08.030.

Article  PubMed  Google Scholar 

3.

Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, Muller MCA, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8):1995–2002. https://doi.org/10.1111/jth.14888.

CAS  Article  PubMed  PubMed Central  Google Scholar 

4.

Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers D, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–7. https://doi.org/10.1016/j.thromres.2020.04.013.

CAS  Article  PubMed  PubMed Central  Google Scholar 

5.

Kunutsor SK, Laukkanen JA. Incidence of venous and arterial thromboembolic complications in COVID-19: a systematic review and meta-analysis. Thromb Res. 2020;196:27–30. https://doi.org/10.1016/j.thromres.2020.08.022.

CAS  Article  PubMed  PubMed Central  Google Scholar 

6.

Al-Ani F, Chehade S, Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review Thrombosis Research. 2020;192:152–60. https://doi.org/10.1016/j.thromres.2020.05.039.

CAS  Article  PubMed  Google Scholar 

7.

Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, Berger JS. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA. 2020;324(8):799–801. https://doi.org/10.1001/jama.2020.13372.

CAS  Article  PubMed  PubMed Central  Google Scholar 

8.

Thachil J, Cushman M, Srivastava A. A proposal for staging COVID-19 coagulopathy. Res Pract Thromb Haemost. 2020;4(5):731–6. https://doi.org/10.1002/rth2.12372.

CAS  Article  PubMed  PubMed Central  Google Scholar 

9.

Llitjos JF, Leclerc M, Chochois C, Monsallier JM, Ramakers M, Auvray M, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;18(7):1743–6. https://doi.org/10.1111/jth.14869.

CAS  Article  Google Scholar 

10.

Wichmann D, Sperhake JP, Lutgehetmann M, Steurer S, Edler C, Heinemann A, et al. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann Intern Med. 2020;173(4):268–77. https://doi.org/10.7326/M20-2003.

Article  Google Scholar 

11.

Cavalcanti DD, Raz E, Shapiro M, Dehkharghani S, Yaghi S, Lillemoe K, et al. Cerebral venous thrombosis associated with COVID-19. AJNR Am J Neuroradiol. 2020;41(8):1370–6. https://doi.org/10.3174/ajnr.A6644.

CAS  Article  PubMed  PubMed Central  Google Scholar 

12.

Cheung S, Quiwa JC, Pillai A, Onwu C, Tharayil ZJ, Gupta R. Superior mesenteric artery thrombosis and acute intestinal ischemia as a consequence of COVID-19 infection. Am J Case Rep. 2020;21: e925753. https://doi.org/10.12659/AJCR.925753.

Article  PubMed  PubMed Central  Google Scholar 

13.

Szegedi I, Orban-Kalmandi R, Csiba L, Bagoly Z. Stroke as a potential complication of COVID-19-associated coagulopathy: a narrative and systematic review of the literature. J Clin Med. 2020;9:10. https://doi.org/10.3390/jcm9103137.

CAS  Article  Google Scholar 

14.

Alonso MN, Mata-Forte T, García-León N, Vullo PA, Ramirez-Olivencia G, Estébanez M, et al. Incidence, characteristics, laboratory findings and outcomes in acro-ischemia in COVID-19 patients. Vasc Health Risk Manag. 2020;16:467–78. https://doi.org/10.2147/vhrm.S276530.

CAS  Article  PubMed  PubMed Central  Google Scholar 

15.

Philipponnet C, Aniort J, Chabrot P, Souweine B, Heng AE. Renal artery thrombosis induced by COVID-19. Clin Kidney J. 2020;13(4):713. https://doi.org/10.1093/ckj/sfaa141.

CAS  Article  PubMed  PubMed Central  Google Scholar 

16.

Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–98. https://doi.org/10.1007/s00134-020-06062-x.

CAS  Article  Google Scholar 

17.

Hamade A, Jambert L, Tousch J, Talbot M, Dervieux B, Nazer TE, et al. Systematic duplex ultrasound screening in conventional units for COVID-19 patients with follow-up of 5 days. J Vasc Surg Venous Lymphat Disord. 2020. https://doi.org/10.1016/j.jvsv.2020.11.019.

Article  PubMed  PubMed Central  Google Scholar 

18.

Anti-thrombotics for adults hospitalized with COVID-19 (ACTIV-4). https://ClinicalTrials.gov/show/NCT04505774.

19.

Zarychanski R. Therapeutic anticoagulation in critically ill patients with Covid-19 – preliminary report. medRxiv. 2021;2021(03):10.21252749. https://doi.org/10.1101/2021.03.10.21252749.

CAS  Article  Google Scholar 

20.

Blann AD, Lip GY. Virchow’s triad revisited: the importance of soluble coagulation factors, the endothelium, and platelets. Thromb Res. 2001;101(4):321–7. https://doi.org/10.1016/s0049-3848(00)00419-9.

CAS  Article  PubMed  Google Scholar 

21.

Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(23):2950–73. https://doi.org/10.1016/j.jacc.2020.04.031.

CAS  Article  PubMed  PubMed Central  Google Scholar 

22.

Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, et al. Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence. Circulation. 2020;142(2):184–6. https://doi.org/10.1161/circulationaha.120.047430.

CAS  Article  PubMed  Google Scholar 

23.

Nicolai L, Leunig A, Brambs S, Kaiser R, Weinberger T, Weigand M, et al. Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy. Circulation. 2020;142(12):1176–89. https://doi.org/10.1161/CIRCULATIONAHA.120.048488.

CAS  Article  PubMed  PubMed Central  Google Scholar 

24.

Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120–8. https://doi.org/10.1056/NEJMoa2015432.

CAS  Article  PubMed  PubMed Central  Google Scholar 

25.

Kamel MH, Yin W, Zavaro C, Francis JM, Chitalia VC. Hyperthrombotic milieu in COVID-19 patients. Cells. 2020;9(11):2392. https://doi.org/10.3390/cells9112392.

CAS  Article  PubMed Central  Google Scholar 

26.

Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136(4):489–500. https://doi.org/10.1182/blood.2020006520.

CAS  Article  Google Scholar 

27.

Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18(7):1738–42. https://doi.org/10.1111/jth.14850.

CAS  Article  Google Scholar 

28.

Boschiero MN, Carvalho TA, Marson FAL. Retraction in the era of COVID-19 and its influence on evidence-based medicine: is science in jeopardy? Pulmonology. 2021;27(2):97–106. https://doi.org/10.1016/j.pulmoe.2020.10.011.

Article  PubMed  Google Scholar 

29.

Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–8. https://doi.org/10.1016/S0140-6736(20)30937-5.

CAS  Article  PubMed  PubMed Central  Google Scholar 

30.

Maccio A, Madeddu C, Caocci G, La Nasa G. Multifactorial pathogenesis of COVID-19-related coagulopathy: can defibrotide have a role in the early phases of coagulation disorders? J Thromb Haemost. 2020;18(11):3106–8. https://doi.org/10.1111/jth.15021.

CAS  Article  PubMed  Google Scholar 

31.

Milford EM, Reade MC. Resuscitation fluid choices to preserve the endothelial glycocalyx. Crit Care. 2019;23(1):77. https://doi.org/10.1186/s13054-019-2369-x.

Article  PubMed  PubMed Central  Google Scholar 

32.

Haywood-Watson RJ, Holcomb JB, Gonzalez EA, Peng Z, Pati S, Park PW, et al. Modulation of syndecan-1 shedding after hemorrhagic shock and resuscitation. PLoS ONE. 2011;6(8): e23530. https://doi.org/10.1371/journal.pone.0023530.

CAS  Article  PubMed  PubMed Central  Google Scholar 

33.

Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7(8):e575–82. https://doi.org/10.1016/S2352-3026(20)30216-7.

Article  PubMed  PubMed Central  Google Scholar 

34.

Meizlish ML, Pine AB, Goshua G, Chang CH, Zhang H, Bishai J, et al. Circulating markers of angiogenesis and endotheliopathy in COVID-19. medRxiv. 2020;10:2045894020966547. https://doi.org/10.1101/2020.06.29.20140376.

CAS  Article  Google Scholar 

35.

Fraser DD, Patterson EK, Slessarev M, Gill SE, Martin C, Daley M, et al. Endothelial injury and glycocalyx degradation in critically ill coronavirus disease 2019 patients: implications for microvascular platelet aggregation. Crit Care Explor. 2020;2(9): e0194. https://doi.org/10.1097/CCE.0000000000000194.

Article  PubMed  PubMed Central  Google Scholar 

36.

Yamaoka-Tojo M. Vascular endothelial glycocalyx damage in COVID-19. Int J Mol Sci. 2020;21(24):9712. https://doi.org/10.3390/ijms21249712.

CAS  Article  PubMed Central  Google Scholar 

37.

Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol. 2007;27(8):1687–93. https://doi.org/10.1161/ATVBAHA.107.141911.

留言 (0)

沒有登入
gif